Silencing of GATA3 defines a novel stem cell like subgroup of ETP-ALL
收藏官方服务：
资源简介：
Silencing of GATA3 defines a novel stem cell like subgroup of ETP-ALL
应用场景：
创建时间：
2016-02-26
相关数据集
Identification of the dismal subtype of B-ALL with dysregulation of CDX2 and UBTF
PURPOSE: Advance in the knowledge of genomic basis of B-cell acute lymphoblastic leukemia (B-ALL) has changed the treatment approaches and diagnostic assays and improved their outcome. Despite the rec
NIAID Data Ecosystem110
Amplified EPOR/JAK2 genes define a unique subtype of acute erythroid leukemia
Acute erythroid leukemia (AEL) is a unique subtype of acute myeloid leukemia characterized by prominent erythroid proliferation, whose molecular basis is poorly understood. To elucidate the underlying
NIAID Data Ecosystem50
Chromatin accessibility maps of chronic lymphocytic leukemia identify subtype-specific epigenome signatures and transcription regulatory networks. Homo sapiens
Chronic lymphocytic leukemia (CLL) is characterized by substantial clinical heterogeneity, despite relatively few genetic alterations. To provide a basis for studying epigenome deregulation in CLL, we
NIAID Data Ecosystem40
Identification of epigenetic modifiers essential for growth and survival of AML1/ETO-positive leukemia
Aberrant gene expression patterns in acute myeloid leukemia (AML) with balanced chromosomal translocations are often associated with direct or indirect dysregulation of epigenetic modifiers. Previousl
NIAID Data Ecosystem90
Gene expression profiling of CEBPA double and single mutant and CEBPA wild type AML.
Mutations in CCAAT/enhancer binding protein alpha (CEBPA) are seen in 5-14% of acute myeloid leukemia (AML) and have been associated with a favorable clinical outcome. Most AMLs with CEBPA mutations s
NIAID Data Ecosystem50
